Complications cutanées de l'insulinothérapie un problème iatrogène sur le déclin.

Abscess/chemically induced; Diabetes Mellitus/drug therapy; Drug Hypersensitivity; Humans; Hypoglycemic Agents/administration & dosage/adverse effects/therapeutic use; Insulin/administration & dosage/adverse effects/therapeutic use; Skin Diseases/chemically induced

Abstract :

[en] Insulin therapy is increasingly used. Hopefully, its complications are steadily decreasing in incidence since the introduction of new generations of insulin. The main cutaneous side effects were varied, including lipoatrophy, lipohypertrophy, allergic reactions, infectious abcesses and some idiosyncratic reactions.

Disciplines :

Dermatology

Author, co-author :

Pierard, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Hermanns-Lê, Trinh ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale

Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

French

Title :

Complications cutanées de l'insulinothérapie un problème iatrogène sur le déclin.

Alternative titles :

[en] Cutaneous complications of insulin therapy. A drug-induced condition on the decline.

Publication date :

2005

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

5-6

Pages :

564-5

Peer reviewed :

Peer reviewed

Available on ORBi :

since 23 March 2009

Statistics

Number of views

277 (6 by ULiège)

Number of downloads

3767 (5 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Scherbaum WA. - Insulin therapy in Europe. Diabetes Metab Res Rev, 2002, 18, S50-S56.
Richardson T, Kerr D. - Skin-related complications of insulin therapy, Epidemiology and emerging management strategies. Am J Clin Dermatol, 2003, 4, 661-667.
McNally PG, Jowett NI, Kurinczuk JJ, et al. - Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins. Postgrad Med J, 1988, 64, 850-853.
Murao S, Hirata K, Ishida T, et al. - Lipoatrophy induced by recombinant human insulin injection. Intern Med, 1998, 37, 1031-1033.
Mu L, Goldman JM. - Human recombinant DNA insulin-induced lipoatrophy in a patient with type 2 diabetes mellitus. Endocr Pract, 2000, 6, 151-152.
Griffin ME, Feder A, Tamborlane WV. - Lipoatrophy associated with lispro insulin in insulin pump therapy. Diabetes Care, 2001, 24, 174.
Raile K, Noelle V, Landgraf R, et al. - Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes, 2001, 109, 393-396.
Hauner H, Stockamp B, Haaster B. - Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp Clin Endocrinol Diabetes, 1996, 104, 106-110.
Turner BC, Heijlesen OK, Kerr D, et al. - Impaired absorption and omission of insulin: a novel method of detection using the diabetes advisory system computer model. Diabetes Technol Ther, 2001, 3, 99-109.
Yasuda H, Nagata M, Moriyama H, et al. - Human insulin analog insulin aspart does not cause insulin allergy. Diabetes Care, 2001, 24, 2008-2009.
Lapière ChM, Piérard GE, Hermanns JF, et al. - Unusual extensive granulomatosis after long term use of plastic syringes for insulin injections. Dermatologica, 1982, 165, 559-567.
DeShazo RD, Boehm TM, Kumar D, et al. - Dermal hypersensitivity reactions to insulin: correlations of three patterns to their histology. J Allergy Clin Immunol, 1982, 69, 229-237.
Bollinger ME, Hamilton RG, Wood RA. - Protamine allergy as a complication of insulin hypersensitivity; a case report. J Allergy Clin Immunol, 1999, 194, 462-465.
Lee AY, Chey WY, Choi J, et al. - Insulin-induced drug eruptions and reliability of skin tests. Acta Derm Venereol, 2002, 82, 114-117.
Takata H, Kumon Y, Osaki F, et al. - The human insulin analogue aspart is not the almighty solution for insulin allergy. Diabetes Care, 2003, 26, 253-254.
Guinn TS, Bailey GJ, Mecklenberg RS. - Factors related to discontinuation of subcutaneous insulin infusion therapy. Diabetes Care, 1988, 11, 46-51.
Mecklenberg RS, Benson EA, Benson JrJW, et al. - Acute complications associated with insulin pump therapy: report of experience with 161 patients. JAMA 1984, 252, 3265-3269.
Chantelau E, Spraul M, Muhlhauser I, et al. - Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for Type 1 (insulin-dependent) diabetes mellitus: a one centre experience. Diabetologia, 1989, 32, 421-426.
Wickline CL, Cornitus TG, Butler T. - Cellulitis caused by Rhizomucor pusillus in a diabetic patient receiving continuous insulin pump therapy. Southern Med J, 1989, 82, 1432-1434.
Quatresooz P, Arrese JE, Piérard GE. - Synopsis des dermatomycoses invasives chez l'immunodéprimé. Rev Med Liege, 2003, 58, 690-694.
Anderson JA, Adkinson NF. - Allergic reactions to drugs and biologic agents. JAMA, 1987, 258, 2891-2899.
Hermanns-Lê T, Hermanns JF, Piérard GE. - Juvenile acanthosis nigricans and insulin resistance. Fed Dermatol, 2002, 19, 12-14.
Hermanns-Lê T, Scheen A, Piérard GE. - Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol, 2004, 5, 199-203.
Dische FE, Wernstedt C, Westermark GT, et al. - Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia, 1988, 31, 158-161.
Swift B, Hawkins PN, Richards C, et al. - Examination of insulin injection sites: an unexpected finding of localized amyloidosis. Diabet Med, 2002, 19, 881-882.
Wheatley T, Edwards OM. - Insulin cedema and its clinical significance: metabolic studies in three cases. Diabet Med, 1985, 2, 400-404.